The <scp>340B</scp> Drug Pricing Program, Hospital Prices, and Competition in Commercial Markets
Hospital 340B eligibility reduced commercial drug prices only in competitive markets. These findings suggest that market competition is critical for ensuring that policy-driven hospital cost savings are shared with payers and patients.
Authors
- J. Michael McWilliams
- Kyle Smith
- Sunita M. Desai
- Prianca Padmanabhan
- Jessica Chang
Institutions
- Brigham and Women's Hospital (US)
- Harvard University (US)
- American Health Care Association (US)
- Population Council (US)
- New York University (US)
Publication Details
- Journal
- Health Services Research
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1111/1475-6773.70085
- Primary Topic
- Healthcare Policy and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Arnold Ventures
- Agency for Healthcare Research and Quality